Showing results (31-40 of 91) with videos related to

Sort By:
Pageof 10
Journal of Psychiatric Research|November 14, 2009
Modulation of the mineralocorticoid receptor as add-on treatment in depression: a randomized, double-blind, placebo-controlled proof-of-concept studyChristian Otte, Kim Hinkelmann, Steffen Moritz, et al.
Sleep|December 6, 2003
Sleep endocrine effects of the 11-beta-hydroxysteroiddehydrogenase inhibitor metyraponeHolger Jahn, Falk Kiefer, Mildred Schick, et al.
Depression and Anxiety|February 14, 2006
Megestrol attenuates the hormonal response to CCK-4-induced panic attacksThomas J Raedler, Holger Jahn, Birgit Goedeken, et al.
Alcohol and Alcoholism (Oxford, Oxfordshire)|September 28, 2018
Therapeutic Drug Monitoring of Naltrexone and 6β-Naltrexol During Anti-craving Treatment in Alcohol Dependence: Reference RangesSonja Brünen, Nina Kim Bekier, Christoph Hiemke, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists|September 15, 2004
Adjunctive use of reboxetine in schizophreniaThomas J Raedler, Holger Jahn, Josef Arlt, et al.
Psychotherapy Research : Journal of the Society for Psychotherapy Research|January 11, 2023
A mobile-based aftercare intervention to increase self-esteem in inpatients diagnosed with depression: A randomized controlled trialAlina Bruhns, Anna Baumeister, Georgios Demeroutis, et al.
Journal of Psychiatric Research|May 11, 2010
CCK-4: Psychophysiological conditioning elicits features of spontaneous panic attacksKim Hinkelmann, Alexander Yassouridis, Reinhard Mass, et al.
Neuroscience Letters|March 4, 2014
A novel presenilin 1 mutation (Ala275Val) as cause of early-onset familial Alzheimer diseaseDaniel Luedecke, Jos S Becktepe, Jan T Lehmbeck, et al.
Neuroimage|January 8, 2010
B-spline-based stereotactical normalization of brain FDG PET scans in suspected neurodegenerative disease: impact on voxel-based statistical single-subject analysisFabian Wenzel, Stewart Young, Florian Wilke, et al.
Life Sciences|July 31, 2003
The mineralocorticoid receptor agonist, fludrocortisone, inhibits pituitary-adrenal activity in humans after pre-treatment with metyraponeChristian Otte, Holger Jahn, Alexander Yassouridis, et al.
Pageof 10